直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Spotlight on Upcoming Oral Arguments – March 2018

March 5, 2018

Authored and Edited by Alexander Poonai; Caitlin E. Fowler; Lillian M. Robinson; Elizabeth D. Ferrill

Monday, March 5, 2018

Hyatt v. PATO, No. 17-1722, Courtroom 201

In this appeal, the Federal Circuit will consider whether the PTO exceeded its authority under the Patent Act by promulgating MPEP § 1207.04.  Hyatt argues that MPEP § 1207.04, which governs the reopening of prosecution after appeal, conflicts with the Patent Act and was promulgated in excess of the PTO’s statutory authority because it improperly enables the PTO to delay the appellate process by allowing examiners to reopen prosecution.  The PTO argues that it has the inherent authority to reopen prosecution.  The PTO further argues that the reopening of prosecution does not constitute a “final agency action,” and is therefore not a reviewable decision under the APA. 

VirnetX Inc. v. Apple, Inc., No. 17-1131, Courtroom 203

In this appeal arising from the PTAB, VirnetX contends that the PTAB erred in invalidating its patent.  VirnetX argues that the PTAB erroneously found that a reference asserted by Apple constituted a “printed publication” within the meaning of 35 U.S.C. § 102(b).  Specifically, VirnetX argues that the PTAB erred in presuming the publication was publicly available as of the date printed on the document, despite the absence of any corroborating evidence establishing dissemination on that date.  Apple argues that the date on the face of the document as well as the copyright notice and statement that “[d]istribution of this memo is unlimited” constituted sufficient evidence to support the PTAB’s finding.     

Wednesday, March 7, 2018

Valmont Industries, Inc. v. Lindsay Corp., No. 17-1235, Courtroom 201

Valmont appeals from a PTAB decision finding the challenged claims of its patent directed to a remote user interface to monitor and control irrigation equipment invalid as obvious.  Valmont argues that the statutory and regulatory framework governing inter partes reviews require petitioners to submit all of the grounds and supporting evidence in the petition.  Therefore, Valmont argues that the PTAB impermissibly considered new arguments and evidence submitted for the first time in Lindsay’s reply.  In response, Valmont argues that the challenged evidence was submitted in reply to the patent owner’s response, and thus is permissible under 35 U.S.C. § 312(a)(3).  

Thursday, March 8, 2018

NantKwest, Inc. v. Matal, No. 16-1794, Courtroom 201 (en banc)

The Federal Circuit will sit en banc to rehear the panel’s decision in NantKwest, Inc. v. Matal, 860 F.3d 1352 (Fed. Cir. 2017).  The Court will consider whether the PTO can recover its attorneys’ fees under 35 U.S.C. § 145 when an applicant chooses to commence a proceeding at the U.S. District Court for the Eastern District of Virginia.  The panel held that the PTO’s personnel expenses are part of “[a]ll the expenses of the proceeding.”  The Federal Circuit vacated the panel opinion and decided to consider this case en banc.

The PTO argues that Congress unambiguously expressed its intent to require a patent applicant to pay all expenses associated with their decision to commence a proceeding under § 145.  The PTO argues that § 145 clearly evinces Congress’s intent to place the full economic burden on the applicant, rather than on the public.  NantKwest argues that the “American Rule” creates a presumption that litigants pay their own expenses, which can be rebutted only by a “specific and explicit” statutory provision that establishes a clear Congressional intent to deviate from the American Rule.  NantKwest argues that § 145 does not mention “fees,” let alone “attorneys’ fees,” and therefore, Congress has not demonstrated its intent to deviate from the American Rule.

Tags

Spotlight on Upcoming Oral Arguments

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Contacts

Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Copyright © 2018 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Articles

California Reaches Record $12.75 Million CCPA Settlement with General Motors Over Driver Data

June 4, 2026

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

INCONTESTABLE® Blog

Netflix Prevails in Copyright Infringement Suit Regarding Tiger King

May 14, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP